<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39403681</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>15</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>16</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2046-1402</ISSN><JournalIssue CitedMedium="Internet"><Volume>13</Volume><PubDate><Year>2024</Year></PubDate></JournalIssue><Title>F1000Research</Title><ISOAbbreviation>F1000Res</ISOAbbreviation></Journal><ArticleTitle>Association between Hematological Parameters and Severity of Covid-19 Infections.</ArticleTitle><Pagination><StartPage>517</StartPage><MedlinePgn>517</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">517</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.12688/f1000research.148734.2</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">This study aimed to determine the relationships between hematological parameters- hemoglobin, Total Leucocyte Counts (TLC), platelet counts, Absolute Neutrophil Counts (ANC), Absolute Lymphocyte Counts (ALC), Neutrophil Lymphocyte Ratio (NLR), Systemic Immune Inflammatory Index (SII), Neutrophil Monocyte Ratio (NMR), Platelet Lymphocyte Ratio (PLR) and the severity of COVID 19 infections and their use in predicting severity of COVID-19 infections.</AbstractText><AbstractText Label="METHODS AND MATERIAL" NlmCategory="UNASSIGNED">This was a prospective, observational, single-center study of 573 symptomatic adult inpatients of COVID 19 admitted to our tertiary care center.</AbstractText><AbstractText Label="STATISTICAL ANALYSIS USED" NlmCategory="UNASSIGNED">The above-mentioned hematological parameter levels were noted and compared between the two categories of COVID-19 infection, namely non-severe and severe COVID-19 using logistic regression methods. Their cut-off values were detected using the ROC curve.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The median TLC, ANC, NLR, SII, NMR, PLR were notably higher in patients with severe COVID-19 than in those with non-severe COVID-19. Logistic regression analysis showed that NMR (OR=1.029, p=0.006) and ALC (OR=0.999, p=0.002) were statistically significant independent predictors of COVID-19 severity.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">The hematological parameters mentioned, can be used for predicting severe COVID-19 infections at admission. ALC and NMR levels could be used as hematological markers to predict severity of COVID-19 in adult patients with their cut off values being &lt; 1105 cells/cubic millimeter and &gt; 10.434 respectively.</AbstractText><CopyrightInformation>Copyright: © 2024 Krishnan G et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Krishnan</LastName><ForeName>Gokul</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0001-9714-0904</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karanth</LastName><ForeName>Shubhada</ForeName><Initials>S</Initials><Identifier Source="ORCID">0000-0002-1813-538X</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vidyasagar</LastName><ForeName>Sudha</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>General Medicine, The Voluntary Health Services Hospital, Chennai, Tamil Nadu, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Archit</ForeName><Initials>A</Initials><Identifier Source="ORCID">0000-0001-6582-3444</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Udupi</LastName><ForeName>Anurupa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of General Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Karanth</LastName><ForeName>Suresh</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Hematology and hematooncology, A J Institute of Medical Sciences and Research center, Mangalore, Karnataka, India.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kaniyoor Nagri</LastName><ForeName>Shivashankara</ForeName><Initials>S</Initials><Identifier Source="ORCID">0009-0003-2323-6964</Identifier><AffiliationInfo><Affiliation>Department of General Medicine, Kasturba Medical College, Manipal, Manipal Academy of Higher Education, Manipal, Karnataka, 576104, India.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.25299151.v1</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>F1000Res</MedlineTA><NlmUniqueID>101594320</NlmUniqueID><ISSNLinking>2046-1402</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008875" MajorTopicYN="N">Middle Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012720" MajorTopicYN="Y">Severity of Illness Index</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011446" MajorTopicYN="N">Prospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="Y">SARS-CoV-2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000368" MajorTopicYN="N">Aged</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009504" MajorTopicYN="N">Neutrophils</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D010976" MajorTopicYN="N">Platelet Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007958" MajorTopicYN="N">Leukocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D018655" MajorTopicYN="N">Lymphocyte Count</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008214" MajorTopicYN="N">Lymphocytes</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19; Droplet spread; Inflammation; Hematological; Pandemic; SARS-CoV-2</Keyword></KeywordList><CoiStatement>No competing interests were disclosed.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>30</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>18</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>10</Hour><Minute>17</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>15</Day><Hour>4</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39403681</ArticleId><ArticleId IdType="pmc">PMC11472279</ArticleId><ArticleId IdType="doi">10.12688/f1000research.148734.2</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhu N, Zhang D, Wang W, et al. : A Novel Coronavirus from Patients with Pneumonia in China, 2019. N. Engl. J. Med. 2020 Feb 20;382(8):727–733. 10.1056/NEJMoa2001017</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2001017</ArticleId><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrews MA, Areekal B, Rajesh KR, et al. : First confirmed case of COVID-19 infection in India: A case report. Indian J. Med. Res. 2020 May;151(5):490–492. 10.4103/ijmr.IJMR_2131_20</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/ijmr.IJMR_2131_20</ArticleId><ArticleId IdType="pmc">PMC7530459</ArticleId><ArticleId IdType="pubmed">32611918</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ministry of Health and Family Welfare, Government of India:
COVID-19 India.Accessed on: 2021 April 19.
Reference Source
</Citation></Reference><Reference><Citation>Yan Y, Shin WI, Pang YX, et al. : The first 75 days of novel coronavirus (SARS-CoV-2) outbreak: recent advances, prevention, and treatment. Int. J. Environ. Res. Public Health. 2020 Jan;17(7):2323. 10.3390/ijerph17072323</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph17072323</ArticleId><ArticleId IdType="pmc">PMC7177691</ArticleId><ArticleId IdType="pubmed">32235575</ArticleId></ArticleIdList></Reference><Reference><Citation>Friedman J, Calderón-Villarreal A, Bojorquez I, et al. : Excess out-of-hospital mortality and declining oxygen saturation: the sentinel role of emergency medical services data in the COVID-19 crisis in Tijuana, Mexico. Ann. Emerg. Med. 2020 Oct 1;76(4):413–426. 10.1016/j.annemergmed.2020.07.035</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.annemergmed.2020.07.035</ArticleId><ArticleId IdType="pmc">PMC7377712</ArticleId><ArticleId IdType="pubmed">33012377</ArticleId></ArticleIdList></Reference><Reference><Citation>Looi MK: Covid-19: WHO adds JN.1 as new variant of interest. BMJ. 2023 Dec 21;383:383–2975. 10.1136/bmj.p2975</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p2975</ArticleId><ArticleId IdType="pubmed">38128957</ArticleId></ArticleIdList></Reference><Reference><Citation>Mun-Keat L: Covid-19: WHO adds JN.1 as new variant of interest. BMJ. 2023;383: 2975. 10.1136/bmj.p2975</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.p2975</ArticleId><ArticleId IdType="pubmed">38128957</ArticleId></ArticleIdList></Reference><Reference><Citation>Awoke MA, Adane A, Assefa B, et al. : Hematological parameters and their predictive value for assessing disease severity in laboratory-confirmed COVID-19 patients: a retrospective study. Am. J. Blood Res. 2023 Aug 15;13(4):117–129.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10509465</ArticleId><ArticleId IdType="pubmed">37736538</ArticleId></ArticleIdList></Reference><Reference><Citation>Fan BE, Chong VCL, Chan SSW, et al. : Hematologic parameters in patients with COVID-19 infection. Am. J. Hematol. 2020;95:E131–E134. 10.1002/ajh.25774</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ajh.25774</ArticleId><ArticleId IdType="pubmed">32129508</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, et al. : China Medical Treatment Expert Group for COVID-19. Clinical characteristics of coronavirus disease 2019 in China. N. Engl. J. Med. 2020;382:1708–1720. 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavalcante-Silva LHA, Carvalho DCM, Lima ÉA, et al. : Neutrophils and COVID-19: the road so far. Int. Immunopharmacol. 2021;90: 107233. 10.1016/j.intimp.2020.107233</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2020.107233</ArticleId><ArticleId IdType="pmc">PMC7703515</ArticleId><ArticleId IdType="pubmed">33290963</ArticleId></ArticleIdList></Reference><Reference><Citation>
Ministry of Health and Family Welfare, Government of India. Clinical management protocol for covid-19 (In adults); version 6.
2021 May 24;4–6. Accessed on May 30 2021.
Reference Source
</Citation></Reference><Reference><Citation>Guan WJ, Ni ZY, Hu Y, et al. : Clinical Characteristics of Coronavirus Disease 2019 in China. N. Engl. J. Med. 2020 Apr 30;382(18):1708–1720. Epub 2020 Feb 28. 10.1056/NEJMoa2002032</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa2002032</ArticleId><ArticleId IdType="pmc">PMC7092819</ArticleId><ArticleId IdType="pubmed">32109013</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. : Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020 Mar 28;395(10229):1054–1062. Epub 2020 Mar 11. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. Erratum in: Lancet. 2020 Mar 28;395(10229):1038. PMID: 32171076; PMCID: PMC7270627. 10.1016/S0140-6736(20)30566-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)30566-3</ArticleId><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Richardson S, Hirsch JS, Narasimhan M, et al. : Presenting Characteristics, Comorbidities, and Outcomes Among 5700 Patients Hospitalized With COVID-19 in the New York City Area. JAMA. 2020 May 26;323(20):2052–2059. Erratum in: JAMA. 2020 May 26;323(20):2098. 10.1001/jama.2020.6775</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.6775</ArticleId><ArticleId IdType="pmc">PMC7177629</ArticleId><ArticleId IdType="pubmed">32320003</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta N, Ish P, Kumar R, et al. : Evaluation of the clinical profile, laboratory parameters and outcome of two hundred COVID-19 patients from a tertiary centre in India. Monaldi Arch. Chest Dis. 2020 Nov 9;90(4). 10.4081/monaldi.2020.1507</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/monaldi.2020.1507</ArticleId><ArticleId IdType="pubmed">33169598</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin S, Mao W, Zou Q, et al. : Associations between hematological parameters and disease severity in patients with SARS-CoV-2 infection. J. Clin. Lab. Anal. 2021 Jan;35(1):e23604. Epub 2020 Nov 13. 10.1002/jcla.23604</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcla.23604</ArticleId><ArticleId IdType="pmc">PMC7843261</ArticleId><ArticleId IdType="pubmed">33184946</ArticleId></ArticleIdList></Reference><Reference><Citation>Elshazli RM, Toraih EA, Elgaml A, et al. : Diagnostic and prognostic value of hematological and immunological markers in COVID-19 infection: A meta-analysis of 6320 patients. PLoS One. 2020 Aug 21;15(8):e0238160. 10.1371/journal.pone.0238160</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0238160</ArticleId><ArticleId IdType="pmc">PMC7446892</ArticleId><ArticleId IdType="pubmed">32822430</ArticleId></ArticleIdList></Reference><Reference><Citation>Agrawal A, Tyagi P, Mahavar S, et al. : Study of hematological and biochemical parameters in a cohort of Indian COVID-19 patients admitted in a tertiary care centre. Int. J. Adv. Med. 2020 Dec;7(12):1840–1845. 10.18203/2349-3933.ijam20205045</Citation><ArticleIdList><ArticleId IdType="doi">10.18203/2349-3933.ijam20205045</ArticleId></ArticleIdList></Reference><Reference><Citation>Hemmat N, Derakhshani A, Bannazadeh Baghi H, et al. : Neutrophils, crucial, or harmful immune cells involved in coronavirus infection: a bioinformatics study. Front. Genet. 2020 Jun 9;11:641. 10.3389/fgene.2020.00641</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.00641</ArticleId><ArticleId IdType="pmc">PMC7296827</ArticleId><ArticleId IdType="pubmed">32582303</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X, Li S, Sun Q, et al. : Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis. Front. Med. 2020 Jun 9;7:301. 10.3389/fmed.2020.00301</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2020.00301</ArticleId><ArticleId IdType="pmc">PMC7295898</ArticleId><ArticleId IdType="pubmed">32582743</ArticleId></ArticleIdList></Reference><Reference><Citation>Chaplin DD: Overview of the immune response. J. Allergy Clin. Immunol. 2010 Feb 1;125(2):S3–S23. 10.1016/j.jaci.2009.12.980</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaci.2009.12.980</ArticleId><ArticleId IdType="pmc">PMC2923430</ArticleId><ArticleId IdType="pubmed">20176265</ArticleId></ArticleIdList></Reference><Reference><Citation>Sakaguchi S, Yamaguchi T, Nomura T, et al. : Regulatory T cells and immune tolerance. Cell. 2008 May 30;133(5):775–787. 10.1016/j.cell.2008.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2008.05.009</ArticleId><ArticleId IdType="pubmed">18510923</ArticleId></ArticleIdList></Reference><Reference><Citation>Li T, Lu H, Zhang W: Clinical observation and management of COVID-19 patients. Emerg. Microbes Infect. 2020 Dec;9(1):687–690. 10.1080/22221751.2020.1741327</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/22221751.2020.1741327</ArticleId><ArticleId IdType="pmc">PMC7103696</ArticleId><ArticleId IdType="pubmed">32208840</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Zhong L, Deng J, et al. : High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa. Int. J. Oral Sci. 2020 Feb 24;12(1):8. 10.1038/s41368-020-0074-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41368-020-0074-x</ArticleId><ArticleId IdType="pmc">PMC7039956</ArticleId><ArticleId IdType="pubmed">32094336</ArticleId></ArticleIdList></Reference><Reference><Citation>Ziegler-Heitbrock L, Ancuta P, Crowe S, et al. : Nomenclature of monocytes and dendritic cells in blood. Blood. 2010 Oct 21;116(16):e74–e80. 10.1182/blood-2010-02-258558</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2010-02-258558</ArticleId><ArticleId IdType="pubmed">20628149</ArticleId></ArticleIdList></Reference><Reference><Citation>Gatti A, Radrizzani D, Viganò P, et al. : Decrease of non-classical and intermediate monocyte subsets in severe acute SARS-CoV-2 infection. Cytometry A. 2020 Sep;97(9):887–890. 10.1002/cyto.a.24188</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cyto.a.24188</ArticleId><ArticleId IdType="pmc">PMC7404377</ArticleId><ArticleId IdType="pubmed">32654350</ArticleId></ArticleIdList></Reference><Reference><Citation>Arango Duque G, Descoteaux A: Macrophage cytokines: involvement in immunity and infectious diseases. Front. Immunol. 2014 Oct 7;5:491. 10.3389/fimmu.2014.00491</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2014.00491</ArticleId><ArticleId IdType="pmc">PMC4188125</ArticleId><ArticleId IdType="pubmed">25339958</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Q, Zhu D: The prognostic value of systemic immune-inflammation index (SII) in patients after radical operation for carcinoma of stomach in gastric cancer. J. Gastrointest. Oncol. 2019 Oct;10(5):965–978. 10.21037/jgo.2019.05.03</Citation><ArticleIdList><ArticleId IdType="doi">10.21037/jgo.2019.05.03</ArticleId><ArticleId IdType="pmc">PMC6776812</ArticleId><ArticleId IdType="pubmed">31602335</ArticleId></ArticleIdList></Reference><Reference><Citation>Fois AG, Paliogiannis P, Scano V, et al. : The Systemic Inflammation Index on Admission Predicts In-Hospital Mortality in COVID-19 Patients. Molecules. 2020 Dec 4;25(23):5725. 10.3390/molecules25235725</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25235725</ArticleId><ArticleId IdType="pmc">PMC7731255</ArticleId><ArticleId IdType="pubmed">33291581</ArticleId></ArticleIdList></Reference><Reference><Citation>Rizo-Téllez SA, Méndez-García LA, Flores-Rebollo C, et al. : The Neutrophil-to-Monocyte Ratio and Lymphocyte-to-Neutrophil Ratio at Admission Predict In-Hospital Mortality in Mexican Patients with Severe SARS-CoV-2 Infection (Covid-19). Microorganisms. 2020 Oct 10;8(10):1560. 10.3390/microorganisms8101560</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms8101560</ArticleId><ArticleId IdType="pmc">PMC7600553</ArticleId><ArticleId IdType="pubmed">33050487</ArticleId></ArticleIdList></Reference><Reference><Citation>Krishnan G, Karanth S, Vidyasagar S, et al. : Covid study dataset.Dataset. figshare. 2024. 10.6084/m9.figshare.25299151.v1</Citation><ArticleIdList><ArticleId IdType="doi">10.6084/m9.figshare.25299151.v1</ArticleId></ArticleIdList></Reference><Reference><Citation>: Predictive Value of the Platelet Times Neutrophil-to-Lymphocyte Ratio (SII Index) for COVID-19 In-Hospital Mortality. EJIFCC .2023;34(2) :167-173</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10349308</ArticleId><ArticleId IdType="pubmed">37455846</ArticleId></ArticleIdList></Reference><Reference><Citation>: Role of Hematological Parameters in the Grading of COVID-19 and a Model to Predict the Outcome in Inpatients. Cureus .2023;15(9) : 10.7759/cureus.45276 e45276 10.7759/cureus.45276</Citation><ArticleIdList><ArticleId IdType="doi">10.7759/cureus.45276</ArticleId><ArticleId IdType="pmc">PMC10576849</ArticleId><ArticleId IdType="pubmed">37846240</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>